Clinical trials
Completed Phase 4 Lymphoma, Mantle-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Johnson & Johnson Private Limited | 1 |
| Pfizer | 1 |
| University of Maryland, Baltimore | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Mantle-Cell | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma, Non-Hodgkin | 2 |
| Recurrence | 2 |
| Anemia | 1 |
| Blast Crisis | 1 |
| Burkitt Lymphoma | 1 |
| Dendritic Cell Sarcoma, Interdigitating | 1 |
| Graft vs Host Disease | 1 |
| Hodgkin Disease | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.